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ORIGINAL ARTICLE  
ASSESSING NUTRITIONAL STATUS OF CRITICALLY ILL PATIENTS 
USING SERUM PREALBUMIN LEVELS 
Khushbakht Arbab, Hafsa Majid*, Lena Jafri*, Bushra Akram††, Ahmed Raheem*, 
Bushra Jamil**, Madiha Hashmi***, Aysha Habib Khan* 
Department of Pathology, Combined Military Hospital (CMH) Quetta, *Department of Pathology & Laboratory Medicine, 
**Department of Medicine, ***Department of Anaesthesiology, Aga Khan University, Karachi, ††Dow University of Health Sciences, 
Karachi-Pakistan 
Background: Malnutrition in hospitalized patients, contributes to poor outcomes. Biomarker serum 
prealbumin, can prevent the complications by commencement of nutritional support to improve clinical 
outcomes. This study was designed to assess the association between low serum prealbumin level (<18 
mg/dl), with length of stay and all cause intensive care unit mortality. Methods: This cross-sectional 
study was conducted from July 2016 to July 2017 at Aga Khan University Hospital Karachi Pakistan. 
All consecutive patients, aged between 18 to 70 years, admitted in medical or surgical intensive care 
unit were included. Demographic, clinical history and blood samples for analysing serum prealbumin 
were obtained on first day of admission. Patients were categorized into two groups based on their serum 
prealbumin level (taking <18 mg/dl as low). Results: A total of 139 patients were included in this 
study; 95 (68.3%) were male. Median (Q3-Q1) prealbumin level of 12.3 mg/dl (18.8–8.7) was 
observed with low prealbumin level (<18 mg/dl) in 100 (71.9%) patients. All-cause mortality was 
observed in 26 (26.0%) patients, mortality rate was significantly higher in patients with low prealbumin 
level (26.0% vs. 17.9%), p-value =0.31). Hospital and intensive care unit length of stay were 
statistically insignificantly different between the two groups with p-values of 0.27 and 0.44 
respectively. Conclusion: We did not find association of low serum prealbumin with length of stay and 
mortality. Further research is warranted for the assessment of prealbumin as independent predictor of 
ICU mortality. 
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INTRODUCTION 
According to American Society of Parenteral and 
Enteral Nutrition, malnourishment is defined as “an 
acute, subacute or chronic state of nutrition, in which a 
combination of varying degrees of overnutrition or 
undernutrition with or without inflammatory activity led 
to a change in body composition and diminished 
function”.1 An estimated 2 billion world population is 
malnourished, which is increasing globally but 
especially in developing countries.2  
Poor nutritional status contributes to poor 
outcomes like; prolonged length of stay (LOS) in 
hospital, increased readmission rates, occurrence of 
disease complications. This in turn leads to increased 
overall cost of care and all-cause mortality. Incidence of 
malnutrition in hospitalized patients is estimated to be as 
high as 40–50% of all hospitalized patients.3 If 
identified early, malnourishment in hospitalized patients 
can be prevented by early commencement of nutritional 
support leading to improvement in clinical outcomes 
and reduction in overall cost.  
There are different methods used to classify 
malnutrition ranging from clinical signs and symptoms 
to anthropometric measures and biochemical tests. 
Despite all the advancements in field of healthcare, there 
is variability in malnourishment assessment techniques 
and it is dependent on expertise of personnel assessing 
the nutritional status. Serum albumin is a widely used 
indicator of the status of nutrition4 but due to its long 
half-life of 3–4 weeks; acute changes in nutritional 
status cannot be determined. There is a need to identify 
accurate, rapid and sensitive biomarkers for nutritional 
assessment.   
Prealbumin also known as transthyretin 
provides a recent index of nutritional status. However, 
its predictive value in assessing nutritional status of 
critically ill patients is not well studied. Thus, this study 
was designed to assess clinical utility of prealbumin in 
identifying the nutritional status in critically ill patients 
and evaluate its association with LOS in hospital and 
all-cause mortality. 
MATERIAL AND METHODS  
This cross-sectional study was conducted at 
Departments of Pathology and Laboratory Medicine, 
Medicine and Anaesthesiology of Aga Khan University 
Hospital Karachi Pakistan. Approval of institutional 
ethical review committee was taken before 
commencement of the study (ERC ID: 3930-Pat-ERC- 
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15). Patient admitted to intensive care unit (ICU) within 
12 hours of admission from July 2016 to July 2017 were 
invited to participate in the study after informed consent 
from the legal care taker or guardian. Patients with 
history of chronic liver disease, on dialysis, with history 
of alcohol, and prednisolone intake and diagnosed 
nephrotic syndrome were excluded. Also, the patients 
admitted to wards and then shifted to ICU due to 
deterioration of underlying condition were excluded to 
decrease effect of prolong hospital admission. Patients 
were included before initiation of any nutritional 
support. One hundred and thirty-nine patients were 
finally analysed and followed up till the patients were 
discharged from ICU or after shifted to ward, special 
care or expired during hospitalization. 
Their demographic details such as gender, age, 
weight and height were recorded using structured 
questionnaire and BMI was calculated. Patient’s last two 
months clinical history with regards to hospitalization, 
weight loss, history of vomiting, diarrhoea, anaemia, 
loss of appetite, and difficulty in chewing and 
swallowing was taken along with LOS in ICU, LOS in 
hospital and mortality status. Five millilitres of blood 
sample for prealbumin was collected in a gel tube and 
stored at -80oC until analysis. All enrolled patients were 
observed during their hospital stay for ICU LOS, 
hospital LOS and all-cause mortality.  
Serum prealbumin was analysed by 
nephelometric method on Image 800 Chemistry 
analyser (Beckman Coulter Inc. NY, US) using 
Beckman Coulter’s serum prealbumin kit. For 
assessing system performance and validating results, 
three levels of manufacturer provided internal quality 
controls were run with each batch of prealbumin. 
Serum prealbumin cut-off of >18mg/dl was labelled 
as normal. 
Collected data were entered and analysed 
using Statistical Package for the Social Sciences 
(SPSS version 21 and R version 3.4.3). Normality of 
distribution for continuous variables was assessed 
using Shapiro-Wilk test and appropriate median (Q3-
Q1) was calculated. Categorical variables were 
expressed as frequency and percentage. Patients were 
categorized into two groups based on their 
prealbumin level (<18 mg/dl and ≥18 mg/dl). 
Association of low prealbumin level (<18 mg/dl) 
with categorical variables were examined using the 
Chi-square test. The association between continuous 
variables and low prealbumin level were examined 
using the Mann-Whitney test. A p-value of ≤0.05 was 
taken as criteria for statistical significance. Univariate 
and multivariate logistic regression was performed 
taking low prealbumin levels as independent variable. 
Two-sided p-value of ≤0.05 was taken as criteria for 
statistical significance. 
RESULTS  
A total of 139 patients were included in this study, of 
which 95 (68.3%) were male. Median age of the 
patients was 47 years (64–32) and median BMI was 26 
kg/m² (29.4–24). Majority of the patients 58 (41.7%) 
were either overweight or obese. Median prealbumin 
level was 12.3 mg/dl (18.8–8.7). Low prealbumin level 
(<18 mg/dL) was seen in 100 (71.9%) patients. Fifty-
two (37.4%) of patients, belonged to service of 
neurosurgery, followed by surgery 29 (20.9%), general 
medicine 54 (38.8%), and orthopaedics’ 4 (2.9%). All 
cause ICU mortality was observed in n=33 (23.7%) of 
the study patients. Demographic and other 
characteristics of the patients are presented in table-1.  
Comparison of association of clinical 
characteristics and study outcomes with low and optimal 
prealbumin are presented in table-2.  
Significant association of low prealbumin level 
was observed with history of hospitalization and 
vomiting in past two months. All-cause mortality was 
observed in 33 (23.7%) patients; mortality rate was 
higher in patients with low prealbumin as compare to 
those with level more than 18mg/dl but it was not 
statistically significant {26 (26%) vs. 7 (17.9%) p-value 
= 0.31)}. Median hospital and ICU length of stay were 
different between the two groups (p value >0.05). 
Median prealbumin level was found to be significantly 
higher in survived patients, 13.9 mg/dl (19.1–10.3) vs. 
9.7 mg/dl (16.8–6.8), as compared to patients who 
expired (p-value of 0.02). 
After adjusting for all the potential factors in 
multivariate linear regression analysis, none of the 
factors were found to correlate with prealbumin. Table-3 
depicts the univariate and multivariate analysis of low 
prealbumin blood level against different baseline 
characteristics. 
Table-1: Demographic and clinical characteristics of 
the patients admitted to ICU (n=139) 
Characteristics Frequency (%) or Median 
(IQR) 
Gender 
Male 95 (68.3%) 
Female 44 (31.7%) 
*Age years 47(64-32) 
Up to 50  73 (52.5%) 
≥ 50  66 (47.5%) 
*Body Mass Index (BMI) kg/m2  26.0(29.4-24.0) 
Underweight [<18.5] 5 (3.6%) 
Healthy [18.5 <23] 19 (13.7%) 
Overweight [23- 27] 58 (41.7%) 
Obese [BMI ≥ 27] 57 (41.0%) 
*Prealbumin mg/dl 12.3 (18.8-8.7) 
<18 100 (71.9%) 
≥18 39 (28.1%) 
*Values are expressed as Median (IQR = Interquartile Range) as 
*hypothesis of the normality of the distribution was rejected with 
Shapiro-Wilk test p-value of <0.001 
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Table-2: Comparison of clinical characteristic & study outcomes of patients admitted to ICU with low & 






n = 100 
≥18mg/dL 
n = 39 
**p-value 
Past two months clinical history 
Past Hospitalization 31 (22.3%) 27 (27%) 4 (10.3%) 0.03* 
Weight Loss 50 (36%) 38 (38%) 12 (30.8%) 0.42 
Vomiting 34 (24.5%) 29 (29%) 5 (12.8%) 0.04* 
diarrhoea (2–3 episodes\day) 16 (11.5%) 14 (14%) 2 (5.1%) 0.14 
Loss of Appetite 44 (31.7%) 34 (34%) 10 (25.6%) 0.34 
Difficulty in Chewing 9 (6.5%) 5 (5%) 4 (10.3%) 0.25 
Difficulty in Swallowing 8 (5.8%) 7 (7%) 1 (2.6%) 0.31 
Anaemia 38 (27.3%) 26 (26%) 12 (30.8%) 0.57 
Study Outcomes 
LOS in Hospital (days) Median (IQR) 12 (18–8) 12 (18–8) 11 (16–7) 0.27 
LOS in ICU (days) Median (IQR) 6 (9–3) 6 (10–3) 5 (7–4) 0.44 
All cause ICU mortality 33 (23.7%) 26 (26.0%) 7 (17.9%) 0.31 
*Statistically significant at 0.05 level of significance 
**p-values are based on chi-square test for categorical variables and Mann-Whitney test for continuous variables 
LOS = Length of stay 
ICU = Intensive care unit 
IQR = Interquartile Range 
Table-3: Univariate and multivariate analysis of low prealbumin 
Univariate Analysis Multivariate Analysis  Factors 
OR [95% CI] p-value OR [95% CI] p-value 
Demographics 
Male 1.11 [0.51–2.45] 0.79 1.45 [0.6–3.49] 0.41 
Age > 50 years 1.67 [0.78–3.54] 0.18 1.52 [0.66–3.48] 0.32 
BMI ≥ 23 kg/m2 0.83 [0.3–2.27] 0.71 1 [0.32–3.14] 0.99 
Past two months clinical history 
Past Hospitalization 3.24 [1.05–9.97] 0.04* 2.82 [0.79–10.05] 0.11 
Weight Loss 1.38 [0.63–3.04] 0.42 1.27 [0.46–3.5] 0.63 
Vomiting 2.78 [0.99–7.81] 0.05 2.95 [0.95–9.15] 0.06 
Diarrhoea 3.01 [0.65–13.92] 0.15 2.37 [0.43–13.24] 0.32 
Loss of Appetite 1.49 [0.65–3.42] 0.34 0.73 [0.25–2.18] 0.57 
Difficulty in Chewing 0.46 [0.12–1.81] 0.26 0.47 [0.1–2.25] 0.34 
Difficulty in Swallowing 2.86 [0.34–4.04] 0.33 3.01 [0.32–28.61] 0.33 
Anaemia 0.79 [0.35–1.78] 0.57 0.66 [0.26–1.65] 0.37 
All cause ICU Mortality 1.61 [0.63–4.08] 0.31 1.56 [0.56–4.31] 0.39 
Dependent variable = Low Prealbumin 
OR=Odds Ratio, CI = Confidence interval 
*Statistically significant at 5% level of significance 
 
DISCUSSION  
Since long serum albumin have been utilized by 
physicians for monitoring or evaluation of nutritional 
status. However, it has proved to be an ineffective 
measure for assessing recent changes in nutritional 
status, owing to its large plasma pool and long half-
life of 3–4 weeks. On the other hand, prealbumin, has 
a half-life in plasma of 24–48 hours, which in 
comparison to albumin is much shorter. Hence it is 
relatively more responsive to alterations in energy-
protein status in comparison to albumin and provides 
a better reflection of dietary intake that was recent 
rather than the overall status of the nutrition.5 A raise 
in prealbumin can be expected within 4 days after 
nutritional support has been provided complemented 
with the intake of a high calorie/high protein 
formula.6  
Malnourishment is a common finding in hospitalized 
patients and its early identification and correction is 
imperative for the better outcome of the patients. 
Low prealbumin is reported to be associated with 
higher in-hospital or short-term mortality and post 
procedural complication such as infection, extended 
hospital stays and mechanical support in patients with 
various underlying diseases.7–11 This study was an 
attempt to assess the association between low 
prealbumin (<18 mg/dl), with LOS and all-cause 
mortality in our population.  
In present study, 71.9% of the patients had 
low levels of prealbumin. Association of prealbumin 
was observed with past two month’s history of 
hospitalization and vomiting. Lower prealbumin 
values in patients who expired as compared to those 
who survived were also noted.  While LOS in ICU 
and hospital were longer in subjects with low 
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prealbumin (<18 mg/dl) levels; 6 days (10–3) and 12 
days (18–8) compared to patients with optimal 
prealbumin 5 days (7–4) and 11days (16–7) 
respectively. However, none of the factors were 
significantly associated with serum prealbumin level 
in the regression model in this study. 
Previous study by Cheng V et al12 reported 
that low prealbumin was associated with critically ill 
trauma patients had high rate infections (p<0.001), 
more mortality (p-value 0.007), extended hospital 
stays (p<0.001), and longer ICU stay (p<0.001). 
Another study by Avram et al13 documented that 
serum prealbumin was an independent forecaster of 
mortality in patients suffering from peritoneal 
dialysis. Similarly, another study by Yang HT et al14 
on massively-burned patients observed that serum 
prealbumin was independently associated with 
mortality. A study on critically ill patients by 
Devakonda A et al15 found excellent concordance 
between protein energy malnutrition and serum 
prealbumin, additionally prealbumin levels correlated 
with mortality, ICU and hospital LOS. There are 
some limitations to our study; small sample size, 
single centre cross-sectional study design while serial 
monitoring may serve as a better predictor.  
CONCLUSION 
Low prealbumin concentration was common in 
critically ill patients. However, no association was 
found between low prealbumin and LOS or all-cause 
mortality in our population. For more generalizable 
results, future follow up, prospective and large, 
multicentre researches are needed.  
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